NCI Trials for August 2021

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The National Cancer Institute approved the following clinical research studies last month.  

For further information, contact the principal investigator listed.


Phase I – 10363
A Phase I Study of Pomalidomide and Nivolumab in Patients with Virus-Associated Malignancies with or Without HIV

NCI Center for Cancer Research
Lurain, Kathryn
(301) 250-5156


Phase I/II – 10417
Clinical Evaluation of ASTX727 in Combination with Venetoclax All-Oral Therapy vs Standard of Care Cytarabine and Anthracycline Induction Chemotherapy for Younger FLT3WT Patients with ELN High- Risk Acute Myeloid Leukemia

Yale University Cancer Center LAO
Savona, Michael Robert
(615) 936-3321


Phase I/II – 10428
A Phase I/II Study of Abemaciclib in Patients with HIV-Associated and HIV-Negative Kaposi Sarcoma

NCI Center for Cancer Research
Ramaswami, Ramya
(301) 451-9018


Phase II – NRG-BN010
A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on the Tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Stereotactic Radiotherapy in Recurrent Glioblastoma

NRG Oncology
Bagley, Stephen Joseph
(215) 614-1858


Phase III – URCC-19178
Optimizing Functional Outcomes of Older Cancer Survivors After Chemotherapy

University of Rochester NCORP Research Base
Mohile, Supriya Gupta
(585) 275-9319


Phase Pilot – AMC-111
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living with HIV: A Feasibility Study

AIDS Malignancy Consortium
Sigel, Keith Magnus
(212) 824-7558

Table of Contents

YOU MAY BE INTERESTED IN

President Joe Biden has announced his intent to appoint Monica Bertagnolli as the 16th director of the National Cancer Institute—and the first woman and first chair of a clinical trials cooperative group to be named to the role.The White House announcement Aug. 10 comes nearly three weeks after news of Bertagnolli’s appointment leaked out on Twitter and in the press (The Cancer Letter, July 21, 2022).
Can you imagine, as a radiation oncologist, you have to shelter your patients in a Co-60 vault to protect them from missiles, provide them with water by melting snow, feed them, keep them warm by using a backup power generator, and evacuate them just two hours before the missile destroys the radiation oncology department? 
Research shows that cancer patients who receive navigation have improved survival, access to advanced care like clinical trials, and services like genetic testing and palliative care. Navigation often results in increased screening and patients receiving treatment sooner, resulting in improved quality of life and more cancer-free days.

Login